Sentence examples for trial major from inspiring English sources

In a series of interviews before his two-day trial, Major Bunel admitted that he had been in contact with a Yugoslav officer but said that he was acting on orders from French intelligence officers who were hoping to convince the Yugoslav president, Slobodan Milosevic, that the threat of NATO strikes was real.

During the trial, Major Bunel expanded on this charge, telling the court that he had received a call over a secure internal phone line from a French military intelligence agent urging him to persuade Mr. Milosevic that the only way for Yugoslavia to avoid massive bomb attacks was to pull out of Kosovo.

The deal interrupted a trial, in which Arthur Andersen was the sole defendant Before the trial, major investment banks agreed to more than $6 billion in settlements, while a dozen former board members settled for $24.75 million.

In this trial, major bleeding was significantly reduced by 50%% with the use of rivaroxaban compared with standard of care (HR 0.49; 95 % CI 0.31 0.79; p = 0.003).

While preparing for the U-PROFIT trial, major effort was put into building the software, implementing the U-PRIM system and testing it.

Phone hacking ended up in numerous trials, major financial damage to a mighty company and a newspaper editor sent to prison.

While Japanese officials had to face the Tokyo Trials, major German war crimes were dealt with at the Nuremberg Trials.

As in the RE-COVER trials, major or CRNM bleeding was significantly lower with the use of dabigatran compared with warfarin (HR 0.54; 95 % CI 0.41 0.71).

Despite the encouraging results of phase I and phase II trials, major shortcoming of vaccine still existed which included the variation in generation of protective threshold titers.

In a meta analysis of the large placebo-controlled trials, major bleeding was shown to have occurred in 2.4% of patients treated with Gp IIb/IIIa inhibitors versus 1.4% for placebo (P < 0.0001).

Major clinical trial after major clinical trial has failed to identify novel therapeutic approaches that can be used in daily clinical practice as add-on to renin-angiotensin system blockade to improve outcomes [ 10].